Robotic Radiotherapy Market Size, Share, Trends & Forecast, 2026–2034
REPORT DETAILS
Robotic Radiotherapy Market Summary
The global robotic radiotherapy market size was valued at USD 1.54 billion in 2025. The market is projected to grow at an 11.67% CAGR from 2026 to 2034. Technological advancements in robotics systems and growing demand for minimally invasive treatments are a few of the key factors driving market growth. The market is also witnessing increased demand due to rising cancer prevalence globally.
Market Statistics
Robotic Radiotherapy Market Key Takeaways
- North America accounted for an 41.0% robotic radiotherapy market share in 2025. This is because of its advanced healthcare system and research investments.
- The Asia Pacific region will grow at a 14.20% CAGR. Growth in the regional market is because of an increase in cancer patients and government investments.
- The radiotherapy systems segment dominated the market with 64.0% share in 2025. This is because of their significance in delivering radiation and implementing the treatment plan.
- The linear accelerators segment dominated with an 66.0% share in 2025. The linear accelerators technology is widely used due to its precise radiation dose management.
- The prostate cancer segment is projected to grow at a 12.70% CAGR. The rising prevalence of prostate cancer is contributing to the segment’s rapid growth.
Note: Figures and projections outlined in this report are the result of Polaris Market Research’s proprietary analytical processes, grounded in the latest available datasets and market observations.
What Is the Robotic Radiotherapy Market?
The robotic radiotherapy market consists of the development, manufacturing, and use of robotic systems that are intended to provide accurate radiotherapy to cancer patients. They use robotics, sophisticated imaging, and treatment planning software to focus radiation directly on tumors while protecting nearby healthy tissue. Medical imaging is done before treatment to define precisely where the tumor is, what its shape is, and how big it is, and then the radiation is delivered from multiple angles to focus the dose at the tumor site. Some systems employ real-time motion tracking to detect tumor movement from breathing or patient position shifts, ensuring radiation stays precisely focused throughout the entire treatment. The market also includes related technologies such as real-time imaging and adaptive treatment planning systems, which play a crucial role in precision radiation oncology.
How Does Robotic Radiotherapy Work?
Robot-assisted radiotherapy uses robotic devices, advanced imaging technologies, and treatment planning software for delivering radiation therapy to the affected tumors. Usually, this treatment procedure starts with imaging that helps identify the characteristics of the tumor, including its size, shape, and location. Cone-beam CT (CBCT) may help the treatment team obtain an image of the tumor before and during the procedure.
Hypofractionation is one of the methods used in some treatment plans where large amounts of radiation are delivered in a few treatments. The imaging and feedback systems during each treatment enable accurate delivery of radiation. These capabilities make radiotherapy important in precision radiation oncology.
Robotic Radiotherapy vs. Conventional Radiotherapy
Robotic and traditional radiotherapy involve the utilization of radiation therapy in cancer treatment; however, the two differ in terms of planning, delivery, and modification of the treatment procedure. The robotic approach involves advanced robotics and imaging technology, while the traditional method makes use of fixed-position treatment and existing radiation treatment procedures.
| Feature | Robotic Radiotherapy | Conventional Radiotherapy |
| Delivery of radiation | Uses robotics for the delivery of radiation at multiple angles | Radiation is mostly delivered using predefined treatment positions and beam angles |
| Targeting tumors | Aids in very precise targeting of tumors | Tumor targeting is done in accordance with the treatment plan |
| Motion management | Can either detect or compensate for motion during treatments | Motion management depends on the treatment modality used |
| Imaging | Allows advanced imaging to be used during treatments | Uses imaging in the treatment planning stage |
| Planning of treatments | Allows flexible and individual treatment planning | Use of conventional treatment planning approaches |
| Number of treatments | May allow hypofractionation in fewer sessions for some patients | Number of treatments varies by cancer type and treatment plan |
| Technology | Use of robotics, imaging, radiation systems, and software | Mainly uses linear accelerators |
| Key advantage | High level of flexibility and precision in treatments | Well-known and clinically tested method |
Source: Polaris Market Research Analysis
Source: Polaris Market Research Analysis
Robotic Radiotherapy Market Dynamics
The integration of artificial intelligence (AI) and machine learning (ML) into robotic radiotherapy systems presents a substantial market potential. These technologies enable adaptive treatment planning and real-time adjustments, further optimizing radiation delivery. The growing geriatric population, which is more susceptible to cancer, is also contributing to the expanding market size. Additionally, the rising awareness of the benefits associated with robotic radiotherapy, such as reduced side effects and shorter recovery times, is fostering increased market penetration. Understanding these market trends is crucial for stakeholders conducting market entry assessments and developing strategic plans to capitalize on the evolving healthcare landscape.
Driver: Technological Advancements in Robotic Systems and Imaging
The continuous evolution of robotic systems and advanced imaging technologies is a paramount driver for the robotic radiotherapy market. Integrating high-precision robotic arms with real-time imaging capabilities, such as cone-beam computed tomography (CBCT), enhances the accuracy of radiation delivery. For instance, in May 2026, Accuray Incorporated announced a new 10‑year strategic collaboration with the University of Wisconsin School of Medicine and Public Health (UW SMPH). The alliance intends to create personalized cancer treatments using the Stellar adaptive radiation treatment system of Accuray (source: accuray.com). The focus on reducing side effects and increasing the effectiveness of radiation therapy through precise targeting is a major market driver. This continual innovation directly translates to increased adoption rates, thereby propelling the growth of the robotic radiotherapy market.
Driver: Increasing Prevalence of Cancer and Demand for Minimally Invasive Treatments
The rising global incidence of cancer is a significant factor propelling the robotic radiotherapy market. As cancer cases rise, there is a growing demand for effective and less invasive treatment options. According to WHO’s global status report on cancer 2026, cancer is the second leading cause of death globally. The report estimates that there are 20.6 billion new cancer cases and close to 10 billion cancer deaths annually. The number of annual cancer cases is projected to grow to 35 billion by 2050 (source: who.int). Additionally, patients are increasingly seeking treatments that minimize discomfort and recovery time. Robotic radiotherapy, with its precision and reduced impact on healthy tissues, aligns with this demand. The ability to deliver high doses of radiation to tumors while sparing surrounding organs is a key advantage, leading to higher patient satisfaction and treatment efficacy. This growing need for minimally invasive, effective cancer treatments is a substantial market demand trend, thereby fostering expansion within the robotic radiotherapy market.
Driver: Government Initiatives and Healthcare Infrastructure Development
Government initiatives and investments in healthcare infrastructure are vital catalysts for the robotic radiotherapy market. Many countries are implementing programs to improve cancer care, which includes the adoption of advanced radiotherapy technologies. In July 2026, the Government of India reported that the ₹3,420 crore PLI Scheme of Medical Devices of India includes medical equipment and devices used for cancer care and radiation therapy, along with radiology and imaging devices. According to the government, 27 projects have been approved under this scheme, which includes an investment of ₹1,153.07 crore for the manufacturing of equipment, including LINAC, MRI, and CT (source: pib.gov.in). Moreover, improvements in healthcare infrastructure, particularly in developing regions, are facilitating the accessibility of advanced treatments. Governmental support and infrastructure development are key factors that drive the robotic radiotherapy market.
Challenges: The high costs of equipment, system complexity
The high costs of equipment are one of the main challenges faced by the robotic radiotherapy market. Particularly, it is difficult for smaller hospitals and healthcare centers to make the significant investment needed to purchase the systems. System complexity is yet another issue. The systems available must work with current imaging and treatment planning systems. Integration requires not only time but also technical expertise. The lack of trained professionals could be an additional challenge that may limit the use of robotic radiotherapy technology. Robotic radiotherapy devices need trained individuals to use them on a daily basis as well as perform regular maintenance. The small health facilities may experience challenges in training these professionals due to their limited resources. This may slow the adoption of robotic radiation therapy equipment, especially for organizations with limited financial and technical resources.
Opportunity: Growing Demand for Advanced Radiotherapy in Emerging Markets
Increased infrastructure for cancer care in developing nations has opened up avenues for robotic radiotherapy suppliers. A rising number of cancer patients, better access to health care facilities, and development of advanced technology have prompted health institutions to improve their treatment systems. Increased availability of linear accelerators, advanced imaging technology, and image-guided treatment systems may help promote adoption of robotic radiotherapy. Suppliers of affordable and localized solutions would gain an advantage from the growing demand in these regions.
Opportunity: Advanced Technologies in Robotic Radiotherapy
- AI-guided radiotherapy planning: AI assists in evaluating the patient and image data to make an effective treatment plan and improve radiation delivery.
- Tumor motion tracking: Tumor motion tracking is done through tumor motion trackers, which help in maintaining accuracy in radiation delivery.
- Cone beam computed tomography (CBCT): CBCT provides quality images during treatment and ensures that the patient's positioning is correct for radiation delivery.
- Magnetic resonance imaging-guided radiation therapy: MRI helps visualize the tumors and tissues while delivering the radiation.
- Adaptive radiation therapy: The treatment plans may be modified due to changes in the shape, size, and patient anatomy in the course of treatment.
- Robotic motion control: The robotic arms help in moving around the patient and delivering radiation from multiple angles for targeting hard-to-reach tumors.
- Hypofractionation: With modern equipment, higher doses of radiation can be delivered to patients in a few sessions.
Source: Polaris Market Research Analysis
Robotic Radiotherapy Market Segment Insights
By Product
The robotic radiotherapy market is segmented by product into radiotherapy systems, software, 3D cameras, and others. The radiotherapy systems segment led with a 64.0% share in 2025. This is attributed to their integral role in direct radiation delivery. These advanced systems, which combine robotic precision with radiation emission, are essential for executing complex treatment plans. The continued development of integrated platforms that enhance accuracy and efficiency is a significant factor in maintaining this sub-segment's leading position. This segment reflects the core technology driving the overall market's expansion and adoption.
The software segment is projected to account for an 13.40% CAGR. The increasing complexity of treatment planning and delivery necessitates sophisticated software solutions for data processing, image analysis, and treatment optimization. The demand for advanced algorithms that enable real-time adjustments and personalized treatment protocols is driving rapid innovation in this area. As healthcare providers seek to maximize the benefits of robotic radiotherapy, the need for robust and adaptable software solutions continues to expand, reflecting a strong upward trajectory for this subsegment.
| Segments | Description | Market Share |
| Robotic Radiotherapy Systems | System that emits radiation to the tumor and combines robotic accuracy with technology for treatments. | Largest share |
| Software | Provides support in planning, imaging, optimization of the treatment process, and making changes in real time. | Fastest growing |
| 3D Cameras | Used to capture patient positioning data. | Supporting segment |
| Others | Other products used in robotic radiotherapy systems. | Supporting segment |
Source: Polaris Market Research Analysis
By Technology
The robotic radiotherapy market is segmented by technology into linear accelerators, conventional linear accelerators, MRI-linear accelerators, stereotactic radiation therapy systems, cyberknife, gamma knife, particle therapy, proton beam therapy, and heavy ion beam therapy. The linear accelerators segment led with an 66.0% share in 2025. These systems, known for their versatility and established clinical efficacy, form the backbone of many radiotherapy treatments. The widespread adoption of linear accelerator technology, driven by its ability to deliver precise radiation dose management, contributes significantly to its dominant position in the market. The consistent refinement of linear accelerator capabilities, including integration with advanced imaging, ensures its continued relevance and broad applicability.
The MRI-linear accelerators segment is projected to grow at a 28.0% CAGR. The integration of magnetic resonance imaging (MRI) with linear accelerators enables real-time visualization of tumors and surrounding tissues during treatment. This capability allows for adaptive radiotherapy, where treatment plans are dynamically adjusted based on tumor movement and changes. The increasing demand for personalized and highly precise radiotherapy solutions is fueling the rapid adoption of MRI-linear accelerators. This technological advancement addresses the need for enhanced accuracy and reduced side effects, driving its accelerated growth trajectory within the market.
| Technology | Function | Market Share |
| Linear Accelerators | Precise radiation delivery and used for many types of cancers. | Largest share |
| Conventional Linear Accelerators | Radiation delivery for normal treatments. | Established |
| MRI Linear Accelerators | Use of MRI imaging along with radiation delivery. | Fastest growing |
| Stereotactic Radiation Therapy Systems | Highly focused radiation delivery. | Growing |
| Cyberknife | Robotic positioning with precise radiation delivery. | Established |
| Gamma Knife | Specialized radiation delivery for special tumors and lesions. | Established |
| Particle Therapy | Treatment of cancer with the use of charged particles. | Emerging |
| Proton Beam Therapy | Treatment of tumors with the use of protons. | Growing |
Source: Polaris Market Research Analysis
By Application
The robotic radiotherapy market is segmented by application into prostate cancer, breast cancer, lung cancer, head & neck cancer, colorectal cancer, and other cancers. The lung cancer segment led with an 22.0% share in 2025. This prominence stems from the rising global incidence of lung cancer and the complexity of its treatment, which often necessitates precise and targeted radiotherapy. Robotic radiotherapy systems offer advantages such as improved accuracy in delivering radiation to lung tumors while minimizing damage to surrounding healthy lung tissue, driving widespread adoption in these clinical settings.
The prostate cancer segment is projected to grow at a 12.70% CAGR. The rising prevalence of prostate cancer, coupled with the increasing adoption of advanced radiotherapy techniques for localized prostate tumors, is fueling this expansion. The growing availability of robotic radiotherapy technologies that enable high precision for this cancer type is driving growth. Furthermore, the focus on minimizing side effects and improving patient outcomes in prostate cancer treatment is driving the demand for advanced robotic radiotherapy solutions.
| Use | Key Role | Market Share |
| Lung Cancer | Helps deliver accurate radiation therapy to tumor sites while minimizing the exposure of lungs. | Largest market share |
| Prostate Cancer | Helps deliver targeted therapy to localized tumors while emphasizing side effect minimization. | Fastest growing market segment |
| Breast Cancer | Helps deliver accurate radiation therapy while minimizing exposure to healthy tissues. | Established |
| Head and Neck Cancer | Helps target tumors near vital body tissues and organs. | Growing |
| Colorectal Cancer | Helps deliver targeted radiation therapy for cancer management. | Growing |
| Others | Includes all other cancers being managed using robotic radiotherapy techniques. | Supporting |
Source: Polaris Market Research Analysis
By End User
The robotic radiotherapy market is segmented by end user into hospitals, independent radiotherapy centers, ambulatory surgery centers (ASCs), specialty cancer centers, and academic & research institutions. Hospitals led with an 48.0% share in 2025. This dominance is attributed to the comprehensive infrastructure and multidisciplinary care teams available in hospital settings, which are essential for implementing and managing complex robotic radiotherapy treatments. The established patient base and the ability to integrate robotic radiotherapy with other hospital services further solidify the hospital's leading role in market adoption.
Independent radiotherapy centers are projected to account for a 12.90% CAGR. The increasing specialization and focus on outpatient care are driving the expansion of these centers. These facilities offer streamlined services and often provide a more accessible and cost-effective alternative to hospital-based treatments. The increasing demand for specialized, patient-centric radiotherapy services outside of traditional hospital settings is contributing to the rapid growth of independent radiotherapy centers within the market.
| End User | Key Role | Market Position |
| Hospitals | Provides total cancer treatment with state-of-the-art facilities and multidisciplinary teams. | Largest market share |
| Independent Radiation Therapy Centers | Provides specialty and outpatient radiation therapy treatment services. | Strong growth |
| Ambulatory Surgery Centers (ASCs) | Offers specialized outpatient procedures and treatment. | Emerging |
| Specialty Cancer Clinics | Provides specialty treatment and advanced radiation therapy. | Growing |
| Academic and Research Institutions | Provides research support for innovation, testing, and training. | Supporting segment |
Source: Polaris Market Research Analysis
Real-World Applications
- Robotic radiotherapy for prostate cancer: Robotic radiotherapy is employed for accurate radiation targeting of localized prostate tumors.
- Lung cancer: Robotic technology accounts for the motion of the tumor due to breathing in order for radiation to be accurately targeted.
- Brain and spinal tumors: Treatment with targeted radiation is carried out for tumors that are near vital parts of the body.
- Head and neck cancers: Focused radiation is essential for those patients who have tumors in proximity to sensitive organs.
- Breast cancer: Advanced imaging helps to position the patient and the treatment area accurately.
- Adaptive radiation therapy: Therapy plans are adjusted due to changes in the position of the tumor or anatomy of the patient.
- Hypofractionation: A high radiation dose can be given in short intervals to some patients.
- Image-guided radiation therapy: CBCT and other imaging methods ensure proper targeting of the tumor before radiation.
Source: Polaris Market Research Analysis
Robotic Radiotherapy Market Regional Analysis
North America Robotic Radiotherapy Market
North America led with a 42.0% share in 2025. This region's dominance is attributed to its robust healthcare infrastructure, high adoption rates of advanced medical technologies, and substantial investments in research and development. The presence of leading healthcare institutions and a strong reimbursement framework further facilitates the widespread implementation of robotic radiotherapy systems. The established healthcare ecosystem and a focus on cutting-edge cancer treatment contribute significantly to North America's leading market position.
Europe's Robotic Radiotherapy Market
Europe held a 27.0% market share in 2025. The region’s major market share is due to the presence of the well-established healthcare infrastructure in the region. The increased usage of advanced radiotherapy equipment is fueling the growth of the market. There is an increased interest from hospitals in adopting those technologies that can help improve treatment accuracy. The rise in cancer cases is also adding to the growing demand for advanced solutions for cancer treatment through radiotherapy. The presence of cancer treatment centers further adds to the adoption of advanced medical equipment. European healthcare providers are also concentrating on providing advanced treatment and services to their patients. These factors are driving the adoption of robotic radiotherapy across the region.
Asia Pacific Robotic Radiotherapy Market
Asia Pacific is projected to account for a 14.20% CAGR. This rapid expansion is driven by a confluence of factors, including increasing cancer prevalence, improving healthcare access, and rising disposable incomes. Governments in several countries within the region are investing heavily in upgrading healthcare infrastructure and promoting the adoption of advanced radiotherapy technologies. Furthermore, the growing awareness of minimally invasive treatment options and the increasing availability of skilled healthcare professionals are accelerating the market's growth trajectory in Asia Pacific.
Latin America Robotic Radiotherapy Market
Latin America held a 4.0% market share in 2025. This is owing to gradual improvements in the healthcare infrastructure within the region. The use of radiotherapy technology is growing with the emergence of new treatment options. Increasing spending on cancer treatment is creating opportunities for the introduction of robotic radiotherapy systems. However, lower rates of adoption compared with more developed regions may be observed because of the limitations in the budgets of healthcare institutions and high prices of advanced equipment. The availability of specialized medical institutions also differs between the countries in the region. Still, continued improvements in healthcare access and rising demand for treatment are expected to drive market growth.
Middle East & Africa Robotic Radiotherapy Market
The Middle East & Africa accounted for a 4.0% market share in 2025. This highlights an emerging market for robotic radiotherapy devices. The growth in healthcare infrastructure in terms of cancer management facilities is leading to the need for advanced treatment devices. Healthcare institutions are progressively making use of modernized radiotherapy devices to ensure better treatment capabilities. However, adoption is limited in some countries because of expensive treatment devices and different healthcare infrastructures. Specialist treatment facilities also vary across the region. Despite these challenges, it is expected that healthcare investments and cancer treatment will help the adoption of robotic radiotherapy devices in the Middle East & Africa region.
Regional Market Trends
| Region | Key Market Trend | Market Share in 2025 |
| North America | The market is driven by cancer care systems and increasing utilization of new technology in radiotherapy. | 42.0% |
| Europe | Driven by well-developed health care systems and increasing precision in radiotherapy. | 27.0% |
| Asia Pacific | Growth is supported by increasing cancer cases and investments made in the healthcare industry. | 23.0% |
| Latin America | Cancer treatment infrastructure improvements and demand for advanced treatment drive growth. | 4.0% |
| Middle East & Africa | New healthcare projects and cancer treatment centers support market expansion. | 4.0% |
Source: Polaris Market Research Analysis
Source: Polaris Market Research Analysis
Robotic Radiotherapy Market Competitive Insights
Competitive analysis of the robotic radiotherapy market reveals a dynamic environment characterized by continuous technological advancements and strategic collaborations. Companies are focused on enhancing treatment precision, improving patient outcomes, and expanding their product portfolios. Innovation in areas such as real-time imaging, adaptive radiotherapy, and software integration is crucial for maintaining a competitive edge. The market also sees strategic partnerships and acquisitions aimed at strengthening product offerings and expanding market reach, with companies striving to provide comprehensive solutions that meet the evolving needs of healthcare providers.
Accuray Incorporated, headquartered in Sunnyvale, California, offers the CyberKnife and TomoTherapy systems, which integrate robotic precision with radiation delivery. These systems are designed to deliver highly accurate radiation therapy, minimizing damage to healthy tissues. The company’s focus on innovative technology and patient-centric solutions makes it a key player in the robotic radiotherapy space.
Elekta AB, based in Stockholm, Sweden, provides a range of radiotherapy solutions, including the Versa HD and Elekta Unity systems. These systems combine linear accelerators with advanced imaging and software, enabling precise and adaptive radiation therapy. Elekta’s comprehensive portfolio and commitment to research and development position it as a significant contributor to the advancement of robotic radiotherapy technologies.
Innovation Trends
- MRI-guided radiotherapy: Systems utilizing MR-LINAC technology are advancing, incorporating the capability to deliver radiotherapy based on MRI image acquisition.
- More automated workflow procedures: Companies are now creating automated systems that will assist in some steps of the process, including setup and delivery.
- Integrated treatment platforms: The integration of imaging, treatment planning, and the delivery of the treatment is becoming common practice in radiotherapy.
- Cloud-based radiotherapy software: Cloud computing is being explored to incorporate the treatment plan and to collaborate between oncology teams.
- Smaller and more adaptable systems: There is an effort towards making the systems more adaptable and easy to install.
Cost & Accessibility Factors
- Expensive equipment: The robotic radiotherapy equipment demands significant capital investment. The high robotic radiotherapy cost makes it difficult for small hospitals to install these systems.
- Installation demands: These systems also require a special treatment room, imaging system, and other infrastructure.
- High maintenance: Maintenance costs for these systems also constitute an important factor.
- Skilled workforce: Radiation oncologists, medical physicists, and skilled technicians are necessary for the operation of these systems.
- Lack of availability in rural regions: There is limited availability of such advanced radiotherapy facilities in remote areas, where they are only available in major cities.
- Healthcare funding: Government financing and hospital investments may help in improving the availability of such equipment.
- Emerging market potential: Low cost of systems along with local production of equipment may provide new opportunities for emerging economies.
Vendor Positioning
| Company | Flagship Platform(s) | Technology Focus | Positioning Note |
| Accuray Incorporated | CyberKnife, Radixact | Robotic radiation delivery, image guidance, precision radiotherapy | Strong position in robotic and stereotactic radiotherapy systems. |
| Elekta AB | Elekta Unity, Versa HD | MR-guided radiotherapy, linear accelerators, adaptive treatment | Strong focus on advanced imaging and precision radiation therapy. |
| Varian Medical Systems (a Siemens Healthineers Company) | Ethos, TrueBeam, Halcyon | Adaptive radiotherapy, linear accelerators, image-guided treatment | Broad radiotherapy portfolio with strong focus on adaptive and personalized treatment. |
| Brainlab AG | ExacTrac, Elements | Image guidance, treatment planning, stereotactic radiotherapy | Focuses on software, image guidance, and digital treatment workflows. |
| ViewRay Systems, Inc. | MRidian | MRI-guided radiotherapy | Specialized in real-time MRI-guided radiation treatment. |
| Mitsubishi Electric Corporation | Proton Therapy System | Proton therapy, radiation treatment systems | Provides advanced radiation technologies, including proton therapy systems. |
| Sumitomo Heavy Industries, Ltd. | Proton Therapy System | Proton therapy, particle therapy | Focuses on particle therapy systems for precision cancer treatment. |
| GE HealthCare | SIGNA MRI, Revolution CT | Medical imaging, MRI, CT, image guidance | Major imaging technology provider supporting radiation oncology workflows. |
| RefleXion Medical | X1 | Biology-guided radiotherapy, image-guided radiation therapy | Focuses on advanced radiotherapy using real-time biological signals for treatment guidance. |
Source: Polaris Market Research Analysis
Key Players
- Accuray Incorporated
- Brainlab AG
- Elekta AB
- GE HealthCare
- Mitsubishi Electric Corporation
- RefleXion Medical
- Sumitomo Heavy Industries, Ltd.
- Varian Medical Systems (A Siemens Healthineers Company)
- ViewRay Systems, Inc.
Industry Developments
- May 2026: GE HealthCare introduced its AI-enabled Intelligent Radiation Therapy (iRT) workflow ecosystem, as well as improved MIM software releases, during the ESTRO 2026 Congress in Stockholm with an emphasis on minimizing manual handoffs and increased accuracy in radiation oncology pathways. (source: gehealthcare.com)
- May 2026: The Indian Ministry of Defence revealed that a Ring Gantry-based Linear Accelerator was commissioned into the Department of Radiation Oncology at Army Hospital (Research & Referral), Delhi. This advanced technology is expected to increase in-house treatment capacity for the hospital's significant patient load. (source: pib.gov.in)
Market Segmentation Outlook
| Market Segment | Segments Covered |
| By Product | Radiotherapy Systems; Software; 3D Cameras; Others |
| By Technology | Linear Accelerators; Conventional Linear Accelerators; MRI - Linear Accelerators; Stereotactic Radiation Therapy Systems; CyberKnife; Gamma Knife; Particle Therapy; Proton Beam Therapy; Heavy Ion Beam Therapy |
| By Application | Prostate Cancer; Breast Cancer; Lung Cancer; Head & Neck Cancer; Colorectal Cancer; Other Cancers |
| By End User | Hospitals; Independent Radiotherapy Centers; Ambulatory Surgical Centers; Specialty Clinics; Academic & Research Institutions |
| By Region | North America: U.S., Canada Europe: Germany, France, UK, Italy, Spain, Netherlands, Russia, and the rest of Europe Asia Pacific: China, Japan, India, Malaysia, South Korea, Indonesia, Australia, Rest of Asia Pacific Middle East & Africa: Saudi Arabia, UAE, Israel, South Africa, Rest of Middle East & Africa Latin America: Mexico, Brazil, Argentina, and the rest of Latin America |
Source: Polaris Market Research Analysis
Report Scope
| Report Attributes | Details |
| Market Size Value in 2025 | USD 1.54 billion |
| Market Size Value in 2026 | USD 1.71 billion |
| Revenue Forecast by 2034 | USD 4.15 billion |
| CAGR | 11.67% from 2026 to 2034 |
| Base Year | 2025 |
| Historical Data | 2021–2024 |
| Forecast Period | 2026–2034 |
| Quantitative Units | Revenue in USD billion and CAGR from 2026 to 2034 |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Industry Trends |
| Segments Covered |
|
| Regional Scope |
|
| Competitive Landscape |
|
| Report Format |
|
| Customization | Report customization as per your requirements with respect to countries, regions, and segmentation. |
Source: Polaris Market Research Analysis
How is the Report Valuable for an Organization?
Workflow/Innovation Strategy
The robotic radiotherapy market has been segmented into detailed segments of product, technology, application, and end user. Moreover, the study provides the reader with a detailed understanding of the different segments at both the global and regional levels.
Market Entry Strategies
Growth strategies within the robotic radiotherapy market center on technological innovation and strategic partnerships. Companies are focusing on enhancing system precision and integrating advanced imaging capabilities to improve treatment outcomes. Market penetration is being driven by expanding applications in diverse cancer treatments and increasing awareness of minimally invasive options. Collaborations with healthcare institutions and technology providers are crucial for developing comprehensive solutions. Furthermore, targeted marketing efforts, emphasizing the clinical benefits and cost-effectiveness of robotic radiotherapy, are essential for driving adoption and expanding market reach.
Future Outlook
The robotic radiotherapy market is forecasted to grow due to the uptake of more accurate and personalized treatment tools by providers. There will be increasing interest in MRI-guided radiotherapy and MR-LINAC devices as providers look for ways to increase visibility of the tumor while delivering treatment. AI-powered planning, real-time tumor tracking, and adaptive radiotherapy are also anticipated to help enhance treatment processes. Increased investments in cancer care facilities can lead to new opportunities in the emerging markets. Radiotherapy centers and specialized cancer centers can also contribute to market growth owing to the increasing demand for outpatient treatments. Nevertheless, high costs of equipment, maintenance requirements, and the lack of skilled personnel can continue to restrict adoption in certain geographies.
Robotic Radiotherapy Market FAQ's
The robotic radiotherapy market size was valued at USD 1.54 billion in 2025 and is projected to grow to USD 4.15 billion by 2034.
The market is projected to register a CAGR of 11.67% during the forecast period, 2026-2034.
North America had the largest share of the market accounting for 42.0% share in 2025.
A few of the key players in the market include Accuray Incorporated; Brainlab AG; Elekta AB; GE HealthCare; Mitsubishi Electric Corporation; RefleXion Medical; Sumitomo Heavy Industries, Ltd.; Varian Medical Systems (A Siemens Healthineers Company); and ViewRay Systems, Inc.
The radiotherapy systems segment dominated the market with 64.0% share in 2025
Some of the emerging market trends include the introduction of integrated platforms and the shift towards cloud-based radiotherapy software. Growing demand for advanced radiotherapy in emerging markets is expected to present market opportunities.
High cost of the equipment, installation and maintenance, and the requirement for specialists are the main obstacles that may hinder the implementation of robotic radiotherapy.
Robotic radiotherapy is one of the major advances in the treatment of cancer, using robotics to improve the efficiency of radiotherapy. The main aspect here is the application of robotic devices and imaging systems that make it possible to deliver radiation in high doses to the tumor and reduce the risk of damaging the adjacent healthy tissue.
Robotics technology in radiotherapy utilizes imaging, robotic technology, and treatment software to focus on the tumor from various directions. This allows radiotherapy specialists to target the tumor and minimize the exposure of healthy tissues to radiation.
MRI provides clear images of the tumor and surrounding tissues at the time of therapy. Radiotherapy guided by MRI and MR-LINAC can use this data for adjustments of treatment in case of any changes in the tumor or patient's anatomy.
Download Sample Report of Robotic Radiotherapy Market
Please fill out the form to request a customized copy of the research report.
